肺表面活性物质(PS)在新生儿呼吸衰竭治疗中的疗效分析  

Therapeutic effect of Pulmonary surfactant(PS)on neonatal Respiratory failure

作　　者：韩士中 雅金良 Han Shizhong;Ya Jinliang(Department of Pediatrics,Linquan County People's Hospital,Fuyang 236400,Anhui Province,China)

机构地区：[1]临泉县人民医院儿科,安徽阜阳236400

出　　处：《现代科学仪器》2024年第2期69-73,共5页Modern Scientific Instruments

摘　　要：目的:分析肺表面活性物质(PS)在新生儿呼吸衰竭治疗中的疗效。方法:选取2018年1月~2022年4月临泉县人民医院收治的87例新生儿呼吸衰竭病例,按随机数字表分为对照组(43例)与研究组(44例)。对照组采取生理盐水治疗,研究组采取PS治疗,比较两组的死亡率、血气指标、肺功能指标、总有效率、并发症发生率差异。结果:研究组的死亡率与对照组相近(P>0.05),存活者治疗后的血气指标、肺功能指标优于对照组(P<0.05),总有效率高于对照组(P<0.05),并发症发生率低于对照组(P<0.05)。结论:在新生儿呼吸衰竭治疗中PS的疗效确切。Objective:To analyze the efficacy of Pulmonary surfactant(PS)in the treatment of neonatal Respiratory failure.Methods:87 cases of neonatal Respiratory failure admitted to Linquan County People's Hospital from January 2018 to April 2022 were selected and divided into the control group(43 cases)and the study group(44 cases)according to the random number table.The control group received physiological saline treatment,while the research group received PS treatment.The differences in mortality,blood gas indicators,lung function indicators,total effective rate,and incidence of complications between the two groups were compared.Result:The mortality rate of the study group was similar to that of the control group(P>0.05),and the blood gas and lung function indicators of the survivors after treatment were better than those of the control group(P<0.05).The total effective rate was higher than that of the control group(P<0.05),and the incidence of complications was lower than that of the control group(P<0.05).Conclusion:PS has a definite therapeutic effect in the treatment of neonatal respiratory failure.

关 键 词：肺表面活性物质 同步间歇指令 新生儿呼吸衰竭 血气分析 肺功能 

分 类 号：R725.6[医药卫生—儿科]